| Net Cash Provided by (Used in) Operating Activities |
$492,150 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
3,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
422,533 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$492,150 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$26,574,283 |
USD |
-6.3% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,279,210 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0 |
pure |
|
Q2 2024 |
Q2 2024 |
| Deferred Tax Assets, Gross |
$3,279,210 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$54,224 |
USD |
344% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |